跳到正文
原文
Endpoints News 生物医药· Elizabeth Cairns·· 2026-10-02AI 评分13

#EASD26:Regeneron 展望其减肥药物与降脂疗法的结合应用

#EASD26: Regeneron sees a future combining its obesity drug with lipid-lowering therapy

AI 导读

Regeneron 在 EASD26 上展望其肥胖药物与降脂疗法结合的未来。随着更多 GLP-1 类药物进入后期试验并显示更强的减重效果,希望进入市场的公司正探索相关路径。

正文

MI­LAN — As more GLP-1-based drugs reach late-stage tri­als and post stronger and stronger weight loss ef­fects, com­pa­nies that want to en­ter the mar­ket are look­ing …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

来源:Endpoints News 生物医药 · endpoints.news